Lulette Lipumano-Sanchez, DDS
Dentist · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- 2 Medical Board actions on record
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lipumano-Sanchez’s office at (408) 655-3987 to ask if they take your plan before you enroll.
California Medical Board record
Licence G50950 · Cancelled
Licence status: Cancelled · since 1983 · New York University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 2012-09-07 | Board disciplineDiscipline | Surrender of license. · 16 2011217893 |
| 2011-08-26 | Action in another state or by a federal agencyDiscipline | Texas medical license was assessed a monetary penalty and required continuing medical education (cme). effective 06/19/14 an order of temporary restriction from controlled substances privileges was issued. effective 08/29/14 restricted from controlled substance privileges in schedules ii-v and practice restrictions: restricted from treating patients with chronic pain and shall not supervise or delegate to midlevel providers. · Texas medical board |
Medicaid work
$227,259 in 2024
Medicaid paid $227,259 for 5,860 billed services this clinician did in 2024, up to 131 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 1,353 | $218,452 |
| Service | 613 | $6,660 |
| Service | 331 | $1,058 |
| Service | 133 | $759 |
| Service | 65 | $330 |
| Service | 409 | $0 |
| Service | 281 | $0 |
| Service | 1,769 | $0 |
| Service | 40 | $0 |
| Service | 293 | $0 |
| Service | 60 | $0 |
| Service | 259 | $0 |
| 2024 | 5,860 | 15 | 131 | $227,259 |
| 2023 | 1,837 | 7 | 132 | $227,547 |
| 2022 | 1,339 | 1 | 172 | $203,242 |
| 2021 | 1,757 | 1 | 173 | $262,220 |
| 2020 | 1,471 | 1 | 207 | $216,002 |
| 2019 | 2,477 | 1 | 282 | $357,636 |
| 2018 | 7,274 | 1 | 218 | $1,013,043 |
See the largest Medicaid services in earlier years
2023
| Service | 1,466 | $227,075 |
| Service | 62 | $473 |
| Service | 46 | $0 |
| Service | 47 | $0 |
| Service | 160 | $0 |
| Service | 21 | $0 |
| Service | 35 | $0 |
2022
| Service | 1,339 | $203,242 |
2021
| Service | 1,757 | $262,220 |
2020
| Service | 1,471 | $216,002 |
2019
| Service | 2,477 | $357,636 |
2018
| Service | 7,274 | $1,013,043 |
Drugs they prescribed that Part D paid
$41
Pharmacies billed $41 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 15) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
15 generic and 0 brand-name prescriptions · $41 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 15 | 12 | 0% (0) | 0% | $41 |
| 2022 | 20 | 13 | 0% (0) | 0% | $63 |
| 2021 | 20 | 15 | 0% (0) | 0% | $248 |
| 2020 | 21 | 16 | 0% (0) | 0% | $81 |
| 2019 | 14 | None | None | 0% | $44 |
| 2018 | 22 | 16 | None | 0% | $83 |
| 2017 | 14 | 11 | 0% (0) | 0% | $47 |
| 2016 | 23 | 13 | 0% (0) | 0% | $97 |
| 2015 | 19 | 14 | 0% (0) | 0% | $76 |
| 2014 | 20 | 14 | None | 0% | $111 |
| 2013 | 28 | 18 | None | 0% | $242 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Amoxicillin | 12 | $40 | $3 |
2020: 1 drug
| Amoxicillin | 12 | $45 | $4 |
2019: 1 drug
| Amoxicillin | 11 | $38 | $3 |
2018: 1 drug
| Amoxicillin | 12 | $42 | $3 |
2016: 1 drug
| Amoxicillin | 12 | $51 | $4 |
2014: 1 drug
| Amoxicillin | 14 | $83 | $6 |
2013: 1 drug
| Amoxicillin | 15 | $78 | $5 |
Money from drug and device companies
$52 in 2025
| 2025 | 1 | 2 | None | $52 |
| 2023 | 1 | 2 | None | $35 |
| 2022 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Colgate Oral Pharmaceuticals | None | $52 | 2 payments
|
See all 2 published payments
| Colgate Oral Pharmaceuticals | Education · 2025-12-31 | None | $17 |
| Colgate Oral Pharmaceuticals | Education · 2025-11-26 | None | $35 |
See earlier years (2023, 2022)
2023: $35
| 3m | Filtek | $35 | 2 payments
|
2022: $23
| Kerr | Tf Adaptive | $23 | 1 payment
|
Professional record
- NPI
- 1710179387
- Licence
- CA 50950California G50950: Cancelled
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 122300000X (122300000X)
- Mailing address
- 6223 Tillamook Dr, San Jose, CA, 95123
- NPI first listed
- 2007-08-16
- NPI last updated
- 2008-04-17
This is when the NPI record was last certified, not a medical board exam.